Moody’s Investors Service downgraded its outlook for one of the foremost biomedical research organizations in Cambridge, the Whitehead Institute, saying it expects continued operating deficits as well as cash constraints brought on by the research center's heavy debt load.
Specifically, the credit-ratings firm said it expects continued operating losses at Whitehead through June 2017 and that additional credit downgrades could be in store should the institute fail to improve its financial position.…
![]()
↧